Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Baricitinib is effective as a treatment for severe hair loss.

Semaglutide may help some skin disorders but can also cause skin issues.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Combining lifestyle changes with personalized medication is crucial for better managing obesity in PCOS.

Baricitinib is effective and safe for treating severe alopecia areata.